ICU study of a reversible brain swelling condition
Part of Brain & nervous system clinical trials.
This trial looks at Posterior Reversible Encephalopathy Syndrome (PRES) in adults in the ICU. It may help doctors better understand and manage a condition that can cause seizures, confusion, headaches, and vision problems, and that typically shows specific changes on brain scans.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be age 18 or older
- Be currently admitted to an intensive care unit (ICU)
- Have PRES symptoms, such as confusion/low awareness, seizures, headaches, vision changes, nausea/vomiting, and/or one-sided weakness or other nerve-related symptoms
- Have brain scan changes showing PRES (CT: low-density areas; or MRI showing specific white-matter signal changes like low T1 and high T2/FLAIR)
- Your brain imaging should NOT be normal (it must show abnormalities)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at what causes severe seizure episodes (“status epilepticus”) and a related immune condition that affects the brain (“dysimmune encephalitis”). The goal is to better understand the disease process, which may guide future care.
This study builds a group of adults with sepsis who develop sudden brain problems, like delirium or coma. It aims to better understand how often this happens and how it may be recognized in hospital, which could help future care.
This study looks at how people recover after a prolonged seizure (status epilepticus) in the intensive care unit. It tests thinking and memory skills, and may include a follow-up MRI, to learn more about the brain's healing process.
This trial studies whether using EEG (a brain-wave test) in the ICU can help guide care for people whose seizures keep going despite initial medicines. It may benefit patients with severe, difficult-to-stop status epilepticus by improving how doctors find and treat ongoing seizure activity.
This trial tests a new drug called HRS8179 to reduce severe brain swelling after a large stroke. If you have a major stroke on one side of the brain and can start treatment within 10 hours, this study may help prevent dangerous pressure buildup.
This trial looks at improving outcomes for people who have a potentially life-threatening neurologic illness and are admitted to a Neuro ICU soon after injury. If you qualify, you may receive care strategies being tested to improve recovery and survival.
Hear when a new Posterior Reversible Encephalopathy Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.